|

[68Ga]Ga-ABY-025 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • Vanderbilt-Ingram Cancer Center1

Indications

  • HER 2 Low-expressing Breast Cancer1
  • HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma1
  • Locally Advanced Cancer1
  • HER21
  • Metastatic Cancer1

Nashville, Tennessee1 trial

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Vanderbilt University Medical Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.